首页> 美国卫生研究院文献>Medicina >A Systematic Review of the Role of Prebiotics and Probiotics in Autism Spectrum Disorders
【2h】

A Systematic Review of the Role of Prebiotics and Probiotics in Autism Spectrum Disorders

机译:益生元和益生菌在自闭症谱系障碍中的作用的系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Autism spectrum disorder (ASD) is a complex developmental condition typically characterized by deficits in social and communicative behaviors as well as repetitive patterns of behaviors. Despite its prevalence (affecting 0.1% to 1.8% of the global population), the pathogenesis of ASD remains incompletely understood. Patients with ASD are reported to have more frequent gastrointestinal (GI) complaints. There is some anecdotal evidence that probiotics are able to alleviate GI symptoms as well as improve behavioral issues in children with ASD. However, systematic reviews of the effect of prebiotics/probiotics on ASD and its associated symptoms are lacking. Methods: Using the keywords (prebiotics OR probiotics OR microbiota OR gut) AND (autism OR social OR ASD), a systematic literature search was conducted on PubMed, EMBASE, Medline, Clinicaltrials.gov and Google Scholar databases. The inclusion criteria were original clinical trials, published in English between the period 1st January 1988 and 1st February 2019. Results: A total of eight clinical trials were systematically reviewed. Two clinical trials examined the use of prebiotic and/or diet exclusion while six involved the use of probiotic supplementation in children with ASD. Most of these were prospective, open-label studies. Prebiotics only improved certain GI symptoms; however, when combined with an exclusion diet (gluten and casein free) showed a significant reduction in anti-sociability scores. As for probiotics, there is limited evidence to support the role of probiotics in alleviating the GI or behavioral symptoms in children with ASD. The two available double-blind, randomized, placebo-controlled trials found no significant difference in GI symptoms and behavior. Conclusion: Despite promising preclinical findings, prebiotics and probiotics have demonstrated an overall limited efficacy in the management of GI or behavioral symptoms in children with ASD. In addition, there was no standardized probiotics regimen, with multiple different strains and concentrations of probiotics, and variable duration of treatments.
机译:背景:自闭症谱系障碍(ASD)是一种复杂的发展状况,通常表现为社交和交往行为的缺陷以及行为的重复模式。尽管它的流行(影响全球人口的0.1%至1.8%),但ASD的发病机理仍不完全清楚。据报道,患有ASD的患者有更多的胃肠道(GI)症状。有一些轶事证据表明,益生菌能够缓解ASD儿童的胃肠道症状并改善行为问题。然而,缺乏对益生元/益生菌对ASD及其相关症状的作用的系统评价。方法:使用关键词(益生元或益生菌或微生物群或肠道)和(自闭症或社交或ASD),在PubMed,EMBASE,Medline,Clinicaltrials.gov和Google Scholar数据库上进行了系统的文献搜索。纳入标准为原始临床试验,在1988年1月1日至2019年2月1日期间以英文发表。结果:系统地审查了八项临床试验。两项临床试验检查了益生元和/或饮食排除的使用,而六项涉及在ASD儿童中使用益生菌补充剂。其中大多数是前瞻性开放标签研究。益生元只能改善某些胃肠道症状;但是,与排外饮食(不含麸质和酪蛋白)结合使用时,抗社交能力得分显着降低。至于益生菌,只有有限的证据支持益生菌在缓解ASD儿童的胃肠道或行为症状中的作用。两项可用的双盲,随机,安慰剂对照试验发现,胃肠道症状和行为无明显差异。结论:尽管有令人鼓舞的临床前发现,益生元和益生菌已证明在ASD儿童的胃肠道或行为症状管理中总体疗效有限。另外,没有标准化的益生菌方案,具有多种不同菌株和浓度的益生菌,并且治疗时间可变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号